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Alveolar echinococcosis (AE) is a zoonosis due to the 
larval stages (metacestode) of the tapeworm Echinococcus 
multilocularis. The foxes are enrolled in a sylvatic cycle as 
a definitive host. In humans (intermediate host) the 
metacestode of E.multilocularis proliferate in the liver and 
induce invasive hepatic lesions but also extra-hepatic 
lesions (pulmonary, cerebral, adrenal gland, splenic, bone, 
soft tissue,…).  
The diagnosis is based on epidemiological data, clinical 
findings, serology, clinical imaging, histopathology and in 
some cases E. multilocularis specific PCR assay on tissue.  
Early multidisciplinary care is advised. The radical surgery 
(R0) followed by 2-year of albendazole is the rule.  
 
Until now, Belgium has been considered as low-risk 
country for AE. However, it was recently demonstrated by 
necropsy series that up 60% of the red foxes (Vulpes 
vulpes) may be infected by E. multilocularis in some parts 
of Southern Belgium (Fig 1). The first indigenous Belgian 
human AE cases were described in the early 2000’s.   
  
The aim of this study was to report the experience of the 
CHU Liege, Belgium, with AE management.   
 
Background 
Patients and Methods 
Discussion 
AE appears to be spreading in Belgium and 
has actually an uneven geographical 
distribution with endemicity in areas of 
Southern and Eastern Belgium. However, it is 
probable that local AE cases will be diagnosed 
in the whole country, considering that there is 
no reason that infected foxes remain in 
Southern Belgium and also the fact that some 
people from Northern Belgium might spend 
long period in Southern Belgium, with or 
without their dogs. The liver is the most 
frequently involved organ and the only cure 
can be achieved by complete R0 resection of 
all AE lesions. In reaction to this experience, 
the authors created a multidisciplinary group 
for AE diagnosis and management, including 
hepatologists, infectiologists, microbiologists, 
pathologists, radiologists, nuclear medicine 
specialists, surgeons and veterinarians. The 
authorities should be aware of this medical 
issue. A complete national survey should be 
encouraged, and BASL might have an 
important role in this study 
 ALVEOLAR ECHINOCOCCOSIS IS NOW ENDEMIC 
IN SOUTHERN BELGIUM 
 
A. CAMBIER (1), P. LEONARD (1), B. LOSSON (2), M. HAYETTE (3), J. GIOT (1), N. BLETARD (4), 
P. MEUNIER (5), R. HUSTINX (6), N. MEURISSE (7), J. DELWAIDE (8), P. HONORE (7), O. DETRY (7) 
 [1] Dpt of Infectiology, [2] Dpt of Veterinary Medicine, [3] Dpt of Microbiology, [4] Dpt of Pathology, [5] Dpt of Radiology, [6] Dpt of Nuclear Medicine, 
 [7] Dpt of Abdominal Surgery and Transplantation, [8] Dpt of Hepatogastroenterology  - ECHINO-LIEGE 
 www.echinococcose.be, University of Liege, CHU Liege, Belgium 
Results 
The authors performed a retrospective study of AE 
cases managed between 1999 and 2017 at the CHU 
Sart-Tilman, University of Liège, Belgium. A total of 21 
cases were identified. 
We collected data from epidemiology findings, 
serology, and clinical imaging. The medical files were 
retrospectively reviewed.  
The patients were classified into 3 groups (possible, 
probable and confirmed cases) according to the 




Table I: Patients characteristics 
Sex ratio and mean age at 
the diagnosis 
2/3 are male, 69 years (range: 34-85y),  
Degree of immunosuppression 38% of the patients (2 solid cancer, 2 
hematological cancer, 1 chronic inflammatory 
disease, 3 chronic ethylism, 3 diabetes).  
Risk factors  In all patients risk factors have been highlighted 
(having a dog and/or a cat, living in a rural zone, 
practicing outdoors activities, eating unwashed 
wild strawberries, working as farmer). 
Figure 3: Distribution of indigenous AE human cases 
Figure 1: AE prevalence in red foxes demonstrated by 
necropsy series (Hanosset et al.) 
Table II: Lesions characteristics 
Lesions 
 
-  Hepatic involvement in 20 cases (9 bilateral, 5 the right lobe 
and 6 the left lobe). Only 3 patients presented a lesion strictly 
intrahepatic.  
 
PNM grading Stage I:      3 patients,  
Stage IIIb : 6 patients  
Stage IV:    11 patients.  
Table III: Treatment 
Surgery  11 patients underwent R0 hepatic and extrahepatic surgical 
resections, followed by a two-year (or 6-month for one patient) 
albendazole treatment. The two-year albendazole have been 
stopped because of side effects for one case.  
3 have an R2 surgery (inflammatory phlegmon, persistant 
pulmonary lesions, hepatic lesion followed by a long-term 
albendazole or mebendazole treatment).  
Albendazole 7 patients have unresectable liver lesions and underwent 
albendazole palliative therapy.  
One patient has followed a 2-year albendazole treatment, the 
other one the abendazole was stopped because the patient 
was in palliative care.  
Side effects 45% of the patients presented side effects of albendazole 
Table IV: Evolution of patients 
Evolution 5 patients died ( 3 died of AE, 2 for 
another reason).  
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Asymptomatic Aspecific symptoms (asthenia, 
weight loss) 
Related to liver invasion Other symptoms (lumbar pain, 

















Abdominal lymph nodes 
Adrenal gland 
Peritoneum 
Soft tissue 
Extra-hepatic lesions 
